Samsung NeuroLogica BodyTom CT Financing

Moving a critically ill patient to a fixed CT suite costs time and clinical risk. The Samsung NeuroLogica BodyTom addresses that problem by bringing full-body 32-slice CT scanning to wherever the patient is, the ICU bay, the operating room, the trauma bay, or any space with standard power and sufficient clearance. The revenue model for a BodyTom is different from a fixed-suite scanner: it earns per scan performed in-situ, eliminates transport risk for the clinical team, and sometimes enables procedures that a fixed scanner's room configuration cannot accommodate. Financing a BodyTom is a conversation about what that mobility earns per day in the specific setting where it will operate, and that calculation is worth doing carefully before selecting a structure.

We finance the BodyTom for hospitals, surgical centers, mobile imaging programs, and neurology and trauma programs where point-of-care CT changes the clinical workflow in a documentable way. The platform is a specialty asset with a distinct secondary market profile, and the financing structures we recommend reflect that specificity.

BodyTom Capabilities and Clinical Economics

The BodyTom's 32-slice ring covers a 60 cm bore and scans the full axial body range, not just the head. That distinguishes it from the NeuroLogica CereTom, which is head-only. The BodyTom handles head, chest, abdomen, pelvis, and spine protocols from a self-contained, battery-capable unit that rolls through standard hospital corridors without requiring specialized infrastructure. On a standard electrical supply, it operates for extended periods without interruption.

For hospital operating rooms performing complex neurosurgery, spine surgery, or trauma surgery where intraoperative CT verification affects surgical decision-making, the BodyTom's ability to perform a diagnostic CT without moving the patient off the surgical table changes the operative workflow materially. The per-scan value in that context is directly tied to the clinical outcome improvement from intraoperative imaging, a value that is well-documented in the neurosurgical and spine surgery literature.

For emergency departments and trauma bays, the BodyTom's portability means a critically injured patient can receive immediate CT imaging without the physiological stress and staffing requirements of transport to a fixed suite. That capability is particularly relevant for trauma centers where time from injury to imaging directly affects outcomes on time-sensitive diagnoses like aortic injury and intracranial hemorrhage.

For mobile imaging programs that serve multiple facilities under service contracts, the BodyTom can rotate between locations without the infrastructure requirements of a traditional mobile CT unit mounted in a trailer. The physical flexibility is a competitive advantage in markets where the mobile CT demand is distributed across facilities that cannot all justify or host a trailer unit.

Financing Structure for a Specialty Mobile Asset

The BodyTom's price reflects its specialized capability and the engineering required to deliver diagnostic CT in a portable form factor. It is a meaningful capital investment, and the financing structure needs to respect both the purchase price and the asset's specialty nature. Secondary market activity for the BodyTom is limited relative to fixed-suite CT platforms, which is a factor in operating lease residual value calculations.

For buyers who are committed to the platform for a specific clinical use case, the equipment finance agreement or the CT scanner loan structure produces the cleaner outcome: you own the asset from day one, the payment amortizes the balance, and residual value risk remains with you rather than affecting the monthly payment calculation. Term lengths of 48 to 60 months balance monthly payment against total cost of capital for most programs.

For hospital systems that prefer lease accounting treatment, a capital lease achieves similar economics with a different balance sheet presentation. Operating lease residuals for a specialty mobile platform like the BodyTom may be conservative given the developing secondary market, which is worth factoring into the payment comparison between lease and loan structures.

Programs That Build the Best Case for BodyTom Financing

The BodyTom financing case is strongest when the clinical use is specific and the utilization is predictable. A neurosurgery program that performs a defined number of craniotomies per month and plans to use intraoperative CT on a high share of them can calculate projected scans per week with real specificity. That specificity makes the revenue model credible, and a credible revenue model is the foundation of a fundable financing application.

Mobile imaging service providers who have secured service contracts at multiple facilities before purchasing the BodyTom are in a particularly strong position: contracted utilization demonstrates the revenue side of the financing equation before the first payment is due. We work with programs at both stages, those with contracts in hand and those building toward contracts, and we structure the deal to fit the actual utilization timeline.

Hospital departments that receive capital budget allocation for a BodyTom can finance the purchase with our financing desk even when the allocation represents the full purchase price, because the tax and accounting treatment of a financed acquisition may serve the department better than an outright capital expenditure. We walk through those considerations with the finance team as part of the structure selection process.